市場調查報告書
商品編碼
1469824
全球口腔睡眠呼吸中止裝置市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢與預測Global Oral Sleep Apnea Devices Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032 |
預計到 2032 年,全球口腔睡眠呼吸中止裝置市場的市場規模將從 2023 年的 8.5115 億美元達到近 16.0339 億美元,2024-2032 年研究期間的複合年成長率為 7.29%。
口腔睡眠呼吸中止症裝置或下顎前移裝置 (MAD) 或牙齒矯正器是客製化的口腔裝置,用於治療阻塞性睡眠呼吸中止症 (OSA) 和打鼾。這些裝置在睡眠期間佩戴,可將下顎和舌頭重新定位向前,從而防止氣道塌陷並改善氣流,從而緩解睡眠呼吸障礙的症狀。對於患有輕度至中度 OSA 的個體,口腔睡眠呼吸中止症裝置可以取代持續性正壓呼吸器 (CPAP) 治療。
睡眠呼吸中止症是一種以睡眠期間呼吸中止症為特徵的常見睡眠障礙,其盛行率不斷上升,導致人們對該疾病的認知和診斷不斷提高,從而推動了對口腔睡眠呼吸中止裝置等有效治療方案的需求。這些設備,包括下顎前移裝置 (MAD) 和舌頭固定裝置 (TRD),透過調整下顎或舌頭的位置來在睡眠期間保持氣道開放,從而減輕睡眠呼吸中止症狀的嚴重程度並提高整體睡眠品質。此外,連續呼吸道正壓通氣(CPAP) 治療被認為是睡眠呼吸中止症的基準治療方法,人們越來越傾向於選擇無創且患者友好的治療替代方案,這激發了那些發現CPAP 面罩不舒服或笨重的患者對口腔睡眠呼吸中止裝置的興趣。此外,牙科技術、材料科學和 3D 列印技術的進步催生了客製化和可調節的口腔睡眠呼吸中止裝置,這些裝置可提供更高的舒適度、耐用性和功效,推動市場創新和差異化。
此外,睡眠專家、牙醫和製造商之間不斷加強合作,以提高對睡眠呼吸中止症的認知、改進診斷和最佳化睡眠呼吸中止症的治療方案,透過擴大口腔睡眠呼吸中止症設備的使用範圍和推廣睡眠障礙管理的多學科方法,促進了市場成長。最後,COVID-19 大流行對生活方式改變、壓力水平和睡眠模式中斷的影響提高了人們對睡眠健康的認知以及解決睡眠相關問題的重要性,從而推動了市場對口腔睡眠呼吸中止裝置作為全面睡眠一部分的需求無序的管理策略,進一步推動了市場的擴張。然而,對設備功效、患者依從性以及替代治療選擇的競爭的擔憂可能會挑戰未來幾年的市場成長。
研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外,這些工具也對全球口腔睡眠呼吸中止症設備市場的各個細分市場進行了包容性評估。口腔睡眠呼吸中止症產業的成長和趨勢為這項研究提供了整體方法。
口腔睡眠呼吸中止裝置市場報告的這一部分提供了國家和區域層級細分市場的詳細資料,從而幫助策略家確定相應產品或服務的目標人口統計數據以及即將到來的機會。
本節涵蓋區域前景,重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲口腔睡眠呼吸中止設備市場當前和未來的需求。此外,該報告重點關注所有主要地區各個應用領域的需求、估計和預測。
該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。口腔睡眠呼吸中止設備市場的主要參與者包括 Vendor Landscape、Respironics(Koninklijke Philips NV 的子公司)、Fisher & Paykel Healthcare Limited、Curative Medical, Inc.、React Health(Invacare Corporation 的呼吸產品線)、Somnetics International、 Inc.、BMC Medical Co., Ltd.、Natus Medical Incorporated、SOMNOmedics GmbH、Compumedics、Itamar Medical Ltd.、Nihon Kohden Corporation。本節包含競爭格局的整體視圖,包括各種策略發展,例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。
如果您有任何客製化要求,請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。
The global demand for Oral Sleep Apnea Devices Market is presumed to reach the market size of nearly USD 1603.39 Million by 2032 from USD 851.15 Million in 2023 with a CAGR of 7.29% under the study period 2024 - 2032.
Oral sleep apnea devices, or mandibular advancement devices (MADs) or dental appliances, are custom-fitted oral devices prescribed to treat obstructive sleep apnea (OSA) and snoring. These devices are worn during sleep to reposition the lower jaw and tongue forward, thus preventing airway collapse and improving airflow to alleviate symptoms of sleep-disordered breathing. For individuals experiencing mild to moderate OSA, oral sleep apnea devices offer a substitute for continuous positive airway pressure (CPAP) therapy.
The increasing prevalence of sleep apnea, a common sleep disorder featured by pauses in breathing during sleep, has led to growing awareness and diagnosis of the condition, driving demand for effective treatment options such as oral sleep apnea devices. These devices, including mandibular advancement devices (MADs) and tongue retaining devices (TRDs), work by adjusting the position of the jaw or tongue to maintain an open airway during sleep, lessening the severity of sleep apnea symptoms and enhancing overall sleep quality. Additionally, the rising preference for non-invasive and patient-friendly treatment alternatives to continuous positive airway pressure (CPAP) therapy, considered the benchmark treatment for sleep apnea, has fueled interest in oral sleep apnea devices among patients who find CPAP masks uncomfortable or cumbersome, driving market adoption. Moreover, advancements in dental technology, materials science, and 3D printing techniques have led to custom-fit and adjustable oral sleep apnea devices that offer improved comfort, durability, and efficacy, driving market innovation and differentiation.
Furthermore, the growing collaboration between sleep specialists, dentists, and manufacturers to raise awareness, improve diagnosis, and optimize treatment protocols for sleep apnea has contributed to market growth by expanding access to oral sleep apnea devices and promoting multidisciplinary approaches to sleep disorder management. Lastly, the impact of the COVID-19 pandemic on lifestyle changes, stress levels, and disrupted sleep patterns has heightened awareness of sleep health and the importance of addressing sleep-related issues, driving market demand for oral sleep apnea devices as part of comprehensive sleep disorder management strategies, further fuelling market expansion. However, concerns regarding device efficacy, patient compliance, and competition from alternative treatment options may challenge the market growth in the coming years.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of oral sleep apnea devices. The growth and trends of oral sleep apnea devices industry provide a holistic approach to this study.
This section of the oral sleep apnea devices market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
This section covers the regional outlook, which accentuates current and future demand for the Oral Sleep Apnea Devices market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Oral Sleep Apnea Devices market include Vendor Landscape, Respironics (a subsidiary of Koninklijke Philips N.V.), Fisher & Paykel Healthcare Limited, Curative Medical, Inc., React Health (Respiratory Product Line from Invacare Corporation), Somnetics International, Inc., BMC Medical Co., Ltd., Natus Medical Incorporated, SOMNOmedics GmbH, Compumedics, Itamar Medical Ltd., Nihon Kohden Corporation. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.